Literature DB >> 24522401

Risk prediction models for incident primary cutaneous melanoma: a systematic review.

Kylie Vuong1, Kevin McGeechan2, Bruce K Armstrong1, Anne E Cust1.   

Abstract

IMPORTANCE: Currently, there is no comprehensive assessment of melanoma risk prediction models.
OBJECTIVE: To systematically review published studies reporting multivariable risk prediction models for incident primary cutaneous melanoma for adults. EVIDENCE REVIEW: EMBASE, MEDLINE, PREMEDLINE, and Cochrane databases were searched to April 30, 2013. Eligible studies were hand searched and citation tracked. Two independent reviewers extracted information.
FINDINGS: Nineteen studies reporting 28 melanoma prediction models were included. The number of predictors in the final models ranged from 2 to 13; the most common were nevi, skin type, freckle density, age, hair color, and sunburn history. There was limited reporting and substantial variation among the studies in model development and performance. Discrimination (the ability of the model to differentiate between patients with and without melanoma) was reported in 9 studies and ranged from fair to very good (area under the receiver operating characteristic curve, 0.62-0.86). Few studies assessed internal or external validity of the models or their use in clinical and public health practice. Of the published melanoma risk prediction models, the risk prediction tool developed by Fears and colleagues, which was designed for the US population, appears to be the most clinically useful and may also assist in identifying high-risk groups for melanoma prevention strategies. CONCLUSIONS AND RELEVANCE: Few melanoma risk prediction models have been comprehensively developed and assessed. More external validation and prospective evaluation will help translate melanoma risk prediction models into useful tools for clinical and public health practice.

Entities:  

Mesh:

Year:  2014        PMID: 24522401     DOI: 10.1001/jamadermatol.2013.8890

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  21 in total

Review 1.  Predicting melanoma risk: theory, practice and future challenges.

Authors:  David Whiteman
Journal:  Melanoma Manag       Date:  2014-12-04

Review 2.  Epidemiological and genetic factors underlying melanoma development in Italy.

Authors:  Giuseppe Palmieri; Maria Colombino; Milena Casula; Mario Budroni; Antonella Manca; Maria Cristina Sini; Amelia Lissia; Ignazio Stanganelli; Paolo A Ascierto; Antonio Cossu
Journal:  Melanoma Manag       Date:  2015-05-18

3.  Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.

Authors:  Annette M Molinaro; Leah M Ferrucci; Brenda Cartmel; Erikka Loftfield; David J Leffell; Allen E Bale; Susan T Mayne
Journal:  Am J Epidemiol       Date:  2015-04-08       Impact factor: 4.897

Review 4.  Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

Authors:  M R Roberts; M M Asgari; A E Toland
Journal:  Br J Dermatol       Date:  2019-07-07       Impact factor: 9.302

5.  Independent validation of six melanoma risk prediction models.

Authors:  Catherine M Olsen; Rachel E Neale; Adèle C Green; Penelope M Webb; David C Whiteman
Journal:  J Invest Dermatol       Date:  2014-12-30       Impact factor: 8.551

6.  Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Authors:  Isabelle Kaiser; Sonja Mathes; Annette B Pfahlberg; Wolfgang Uter; Carola Berking; Markus V Heppt; Theresa Steeb; Katharina Diehl; Olaf Gefeller
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

7.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

8.  Effects of fertility drugs on cancers other than breast and gynecologic malignancies.

Authors:  Louise A Brinton; Kamran S Moghissi; Bert Scoccia; Emmet J Lamb; Britton Trabert; Shelley Niwa; David Ruggieri; Carolyn L Westhoff
Journal:  Fertil Steril       Date:  2015-07-29       Impact factor: 7.329

9.  A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.

Authors:  A E Cust; C Badcock; J Smith; N E Thomas; L E Haydu; B K Armstrong; M H Law; J F Thompson; P A Kanetsky; C B Begg; Y Shi; A Kricker; I Orlow; A Sharma; S Yoo; S F Leong; M Berwick; D W Ollila; S Lo
Journal:  Br J Dermatol       Date:  2019-11-27       Impact factor: 9.302

10.  Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.

Authors:  John R Davies; Yu-mei Chang; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adele Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Tim K Lee; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus; Michael S Zens; Andreas Ziegler; Richard P Gallagher; Jennifer H Barrett; Julia Newton-Bishop
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.